Company intelligence / Profile preview

Great Lakes NeuroTechnologies

Cleveland, Ohio, United Statesglneurotech.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

The company's flagship product, KinesiaU™, provides FDA-cleared remote patient monitoring of Parkinson’s disease motor symptoms using a smartwatch and proprietary AI algorithms. It has been validated in hundreds of clinical studies, used by over twenty pharmaceutical companies in trials, recommended by NICE for NHS use in the UK, and supports CPT billing codes for RPM in the US. The company holds more than fifty patents related to real-time monitoring and therapy adjustment.

Therapeutic areas: NeurologyOther
Modalities: DeviceNon-pharmacological therapy (remote monitoring)Software (AI-based algorithms)
Industry: Physiological Monitoring

Partnerships

More than twenty pharmaceutical companies have used their systems in clinical trials.

Beyond the preview

Go deeper on Great Lakes NeuroTechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Great Lakes NeuroTechnologies.

Explore the full profile